Twin Tree Management, LP Astrazeneca PLC Transaction History

Twin Tree Management, LP

$50 Billion
Q3 2024

A detailed history of Twin Tree Management, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Twin Tree Management, LP holds 10,544 shares of AZN stock, worth $692,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,544

Previous 58,723 82.04%

Holding current value

$692,002

Previous $4.58 Million 82.07%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $3.69 Million - $4.22 Million	-48,179 Reduced 82.04%	10,544 $821,000
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $3.92 Million - $4.75 Million	58,723 New	58,723 $4.58 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $1.74 Million - $1.95 Million	28,107 New	28,107 $1.89 Million
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $663,453 - $752,229	10,506 New	10,506 $729,000
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $36.6 Million - $93.6 Million	689,813 New	689,813 $37.8 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $10.7 Million - $12.9 Million	-180,731 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $8.92 Million - $10.7 Million	160,070 Added 774.74%	180,731 $12 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $13.3 Million - $14.5 Million	-238,834 Reduced 92.04%	20,661 $1.24 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $10.5 Million - $13 Million	215,946 Added 495.87%	259,495 $15.5 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $685,989 - $791,884	-14,546 Reduced 25.04%	43,549 $2.17 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $967,343 - $1.16 Million	-19,937 Reduced 25.55%	58,095 $2.9 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $6.62 Million - $7.63 Million	-124,803 Reduced 61.53%	78,032 $4.28 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $8.74 Million - $11.2 Million	202,835 New	202,835 $10.7 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $157,848 - $214,405	-4,177 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $176,973 - $210,317	4,168 Added 46311.11%	4,177 $208,000
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $1.67 Million - $1.89 Million	-41,605 Reduced 99.98%	9 $0
Q2 2019 Aug 12, 2019	BUY	$37.28 - $41.68 $1.4 Million - $1.56 Million	37,492 Added 909.56%	41,614 $1.72 Million
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $117,791 - $142,783	-3,319 Reduced 44.6%	4,122 $167,000
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $14.1 Million - $15.9 Million	-383,115 Reduced 98.09%	7,441 $283,000
Q3 2018 Nov 09, 2018	BUY	$34.76 - $39.72 $8.8 Million - $10.1 Million	253,034 Added 184.0%	390,556 $15.5 Million
Q2 2018 Aug 08, 2018	SELL	$34.55 - $37.05 $4.89 Million - $5.25 Million	-141,597 Reduced 50.73%	137,522 $4.83 Million
Q1 2018 May 09, 2018	BUY	$32.97 - $36.63 $5.81 Million - $6.46 Million	176,234 Added 171.29%	279,119 $9.76 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $2.98 Million - $3.5 Million	102,885	102,885 $3.49 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account

Twin Tree Management, LP Astrazeneca PLC Transaction History